Targeted Alpha-Therapy Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Targeted Alpha-Therapy Market Report 2026

Name: Targeted Alpha-Therapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Isotope Type (Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types), By Application (Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications), By End-User (Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Targeted Alpha-Therapy Market Overview

• Targeted Alpha-Therapy market size has reached to $1.03 billion in 2025

• Expected to grow to $2.25 billion in 2030 at a compound annual growth rate (CAGR) of 17%

• Growth Driver: Rising Adoption Of Precision Medicine Driving The Market Growth Due To Increasing Genetic Testing And Personalized Treatment Approaches

• Market Trend: Advancements In Precision Alpha-Emitter Cancer Treatments

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Targeted Alpha-Therapy Market?

Targeted alpha-therapy (TAT) refers to a form of radiation therapy that delivers highly potent alpha-particle-emitting isotopes directly to cancer cells or diseased tissues. The therapy uses targeting molecules, such as antibodies, peptides, or small molecules, that bind specifically to cancer cell markers, allowing the alpha particles to cause lethal double-strand DNA breaks in nearby cells while minimizing damage to surrounding healthy tissue.

The main isotope types of targeted alpha therapy are actinium-225, radium-223, lead-212, bismuth-213, and others. Actinium-225 refers to a potent alpha-emitting radioisotope widely used in targeted therapies due to its favorable half-life and decay properties. This therapy is applied in conditions including prostate cancer, bone metastases, pancreatic cancer, and others, serving end-users including hospitals, cancer research institutes, specialty clinics, lymphoma, and others.

Targeted Alpha-Therapy Market Global Report 2026 Market Report bar graph

What Is The Targeted Alpha-Therapy Market Size and Share 2026?

The targeted alpha-therapy market size has grown rapidly in recent years. It will grow from $1.03 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to advances in nuclear medicine research, increasing unmet needs in advanced cancers, expansion of radiopharmaceutical clinical trials, availability of medical isotopes, growth in targeted radiation therapy adoption.

What Is The Targeted Alpha-Therapy Market Growth Forecast?

The targeted alpha-therapy market size is expected to see rapid growth in the next few years. It will grow to $2.25 billion in 2030 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to increasing investment in isotope manufacturing infrastructure, rising adoption of personalized radiotherapy, expansion of targeted alpha therapies into new indications, growing regulatory support for radiopharmaceuticals, increasing collaboration between nuclear and oncology specialists. Major trends in the forecast period include increasing development of alpha-emitting radiopharmaceuticals, rising use of targeted radioligand therapies, growing focus on precision radiation delivery, expansion of isotope production capabilities, enhanced integration of targeting molecules.

Book your 30 minutes free consultation with our research experts

Global Targeted Alpha-Therapy Market Segmentation

1) By Isotope Type: Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types

2) By Application: Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications

3) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users

Subsegments:

1) By Actinium-225: Ac-225 Lintuzumab, Ac-225 PSMA-617, Ac-225 DOTATATE

2) By Radium-223: Radium-223 Dichloride (Xofigo)

3) By Lead-212: Pb-212 DOTAMTATE (AlphaMedix), Pb-212 TCMC-Trastuzumab

4) By Bismuth-213: Bi-213 Lintuzumab, Bi-213 DOTATOC

5) By Other Isotope Types: Thorium-227, Astatine-211, Terbium-149

What Is The Driver Of The Targeted Alpha-Therapy Market?

The growing focus on precision medicine is expected to propel the growth of the targeted alpha-therapy market going forward. Precision medicine refers to a healthcare approach that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment for more effective outcomes. Precision medicine is increasing because the growing availability of genetic testing enables more accurate diagnoses and targeted treatments with improved patient outcomes. Targeted alpha-therapy helps in precision medicine by delivering highly potent alpha-emitting isotopes directly to cancer cells, enabling personalized and precise treatment while minimizing damage to healthy tissues. For instance, in March 2024, according to the American Pharmaceutical Review, a US-based journal company, global spending on precision medicine treatments was nearly $32 billion in 2022 and is projected to exceed $124 billion by 2027. Therefore, the growing focus on precision medicine is driving the growth of the targeted alpha-therapy industry.

Key Players In The Global Targeted Alpha-Therapy Market

Major companies operating in the targeted alpha-therapy market are Bayer Aktiengesellschaft, Novartis AG, Lantheus Holdings Inc., Telix Pharmaceuticals Limited, Eckert & Ziegler Strahlen- und Medizintechnik AG, Actinium Pharmaceuticals Inc., RayzeBio Inc., ITM Isotope Technologies Munich SE, ARTBIO Inc., AdvanCell Pty Ltd., IONETIX Corporation, Abdera Therapeutics Inc., Aktis Oncology Inc., Alpha-9 Oncology Inc., Clarity Pharmaceuticals Pty Ltd., Nucleus RadioPharma, Oncoinvent AS, PanTera, Perspective Therapeutics Inc., RadioMedix Inc.

Global Targeted Alpha-Therapy Market Trends and Insights

Major companies operating in the targeted alpha-therapy market are focusing on developing innovative solutions such as peptide receptor radionuclide therapy to improve targeted cancer treatment efficacy, minimize off-target effects, and enhance patient outcomes. Peptide receptor radionuclide therapy (PRRT) refers to a targeted cancer treatment that delivers radioactive isotopes directly to tumor cells by binding them to peptides that specifically attach to receptors overexpressed on cancer cells, thereby minimizing damage to healthy tissue. For instance, in February 2024, RadioMedix Inc., a US-based biotechnology company, partnered with Orano Med, a US-based pharma company, and received the first targeted alpha therapy to win FDA breakthrough device designation is AlphaMedix (lead-212-Dotamtate), aimed at treating neuroendocrine tumors. It is designed to treat advanced gastroenteropancreatic neuroendocrine tumors by delivering highly potent alpha radiation directly to cancer cells while sparing healthy tissue. Its key advantage lies in the high energy and short path length of alpha particles, which cause lethal DNA damage to tumor cells with minimal toxicity. This therapy offers a promising option for patients who are naïve to or have limited response to current beta-emitter treatments, aiming to improve efficacy and safety in difficult-to-treat neuroendocrine tumors.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Targeted Alpha-Therapy Market?

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical industry company, acquired Fusion Pharmaceuticals Inc. for an undisclosed amount. With this acquisition AstraZeneca aims to transform cancer treatment and patient outcomes by developing more precise, targeted next-generation radioconjugate therapies that replace traditional chemotherapy and radiotherapy. Fusion Pharmaceuticals Inc. is a Canada-based biotech company that offers targeted alpha-therapy.

Regional Insights

North America was the largest region in the targeted alpha-therapy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Targeted Alpha-Therapy Market?

The targeted alpha-therapy market consists of sales of neptunium-225 thorium-227 and astatine-211. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Targeted Alpha-Therapy Market Report 2026?

The targeted alpha-therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the targeted alpha-therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Targeted Alpha-Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.2 billion
Revenue Forecast In 2035	$2.25 billion
Growth Rate	CAGR of 17.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Isotope Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Bayer Aktiengesellschaft, Novartis AG, Lantheus Holdings Inc., Telix Pharmaceuticals Limited, Eckert & Ziegler Strahlen- und Medizintechnik AG, Actinium Pharmaceuticals Inc., RayzeBio Inc., ITM Isotope Technologies Munich SE, ARTBIO Inc., AdvanCell Pty L
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Targeted Alpha-Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Targeted Alpha-Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Targeted Alpha-Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Targeted Alpha-Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Development Of Alpha-Emitting Radiopharmaceuticals

4.2.2 Rising Use Of Targeted Radioligand Therapies

4.2.3 Growing Focus On Precision Radiation Delivery

4.2.4 Expansion Of Isotope Production Capabilities

4.2.5 Enhanced Integration Of Targeting Molecules

5. Targeted Alpha-Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cancer Research Institutes

5.3 Specialty Clinics

5.4 Nuclear Medicine Centers

5.5 Oncology Treatment Centers

6. Targeted Alpha-Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Targeted Alpha-Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Targeted Alpha-Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Targeted Alpha-Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Targeted Alpha-Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Targeted Alpha-Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Targeted Alpha-Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Targeted Alpha-Therapy Market Segmentation

9.1. Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Actinium-225, Radium-223, Lead-212, Bismuth-213, Other Isotype Types

9.2. Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate Cancer, Bone Metastases, Pancreatic Cancer, Other Applications

9.3. Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Cancer Research Institutes, Specialty Clinics, Lymphoma, Other End Users

9.4. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ac-225 Lintuzumab, Ac-225 PSMA-617, Ac-225 DOTATATE

9.5. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radium-223 Dichloride (Xofigo)

9.6. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pb-212 DOTAMTATE (AlphaMedix), Pb-212 TCMC-Trastuzumab

9.7. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bi-213 Lintuzumab, Bi-213 DOTATOC

9.8. Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thorium-227, Astatine-211, Terbium-149

10. Targeted Alpha-Therapy Market Regional And Country Analysis

10.1. Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Targeted Alpha-Therapy Market

11.1. Asia-Pacific Targeted Alpha-Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Targeted Alpha-Therapy Market

12.1. China Targeted Alpha-Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Targeted Alpha-Therapy Market

13.1. India Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Targeted Alpha-Therapy Market

14.1. Japan Targeted Alpha-Therapy Market Overview

14.2. Japan Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Targeted Alpha-Therapy Market

15.1. Australia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Targeted Alpha-Therapy Market

16.1. Indonesia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Targeted Alpha-Therapy Market

17.1. South Korea Targeted Alpha-Therapy Market Overview

17.2. South Korea Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Targeted Alpha-Therapy Market

18.1. Taiwan Targeted Alpha-Therapy Market Overview

18.2. Taiwan Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Targeted Alpha-Therapy Market

19.1. South East Asia Targeted Alpha-Therapy Market Overview

19.2. South East Asia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Targeted Alpha-Therapy Market

20.1. Western Europe Targeted Alpha-Therapy Market Overview

20.2. Western Europe Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Targeted Alpha-Therapy Market

21.1. UK Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Targeted Alpha-Therapy Market

22.1. Germany Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Targeted Alpha-Therapy Market

23.1. France Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Targeted Alpha-Therapy Market

24.1. Italy Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Targeted Alpha-Therapy Market

25.1. Spain Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Targeted Alpha-Therapy Market

26.1. Eastern Europe Targeted Alpha-Therapy Market Overview

26.2. Eastern Europe Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Targeted Alpha-Therapy Market

27.1. Russia Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Targeted Alpha-Therapy Market

28.1. North America Targeted Alpha-Therapy Market Overview

28.2. North America Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Targeted Alpha-Therapy Market

29.1. USA Targeted Alpha-Therapy Market Overview

29.2. USA Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Targeted Alpha-Therapy Market

30.1. Canada Targeted Alpha-Therapy Market Overview

30.2. Canada Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Targeted Alpha-Therapy Market

31.1. South America Targeted Alpha-Therapy Market Overview

31.2. South America Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Targeted Alpha-Therapy Market

32.1. Brazil Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Targeted Alpha-Therapy Market

33.1. Middle East Targeted Alpha-Therapy Market Overview

33.2. Middle East Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Targeted Alpha-Therapy Market

34.1. Africa Targeted Alpha-Therapy Market Overview

34.2. Africa Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Targeted Alpha-Therapy Market Regulatory and Investment Landscape

36. Targeted Alpha-Therapy Market Competitive Landscape And Company Profiles

36.1. Targeted Alpha-Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Targeted Alpha-Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Targeted Alpha-Therapy Market Company Profiles

36.3.1. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Telix Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eckert & Ziegler Strahlen- und Medizintechnik AG Overview, Products and Services, Strategy and Financial Analysis

37. Targeted Alpha-Therapy Market Other Major And Innovative Companies

Actinium Pharmaceuticals Inc., RayzeBio Inc., ITM Isotope Technologies Munich SE, ARTBIO Inc., AdvanCell Pty Ltd., IONETIX Corporation, Abdera Therapeutics Inc., Aktis Oncology Inc., Alpha-9 Oncology Inc., Clarity Pharmaceuticals Pty Ltd., Nucleus RadioPharma, Oncoinvent AS, PanTera, Perspective Therapeutics Inc., RadioMedix Inc.

38. Global Targeted Alpha-Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Targeted Alpha-Therapy Market

40. Targeted Alpha-Therapy Market High Potential Countries, Segments and Strategies

40.1 Targeted Alpha-Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Targeted Alpha-Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Targeted Alpha-Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Targeted Alpha-Therapy Market, Overview Of Key Products - Product Examples

Table 2: Global Targeted Alpha-Therapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Targeted Alpha-Therapy Market, Supply Chain Analysis

Table 4: Global Targeted Alpha-Therapy Market, Major Raw Material Providers

Table 5: Global Targeted Alpha-Therapy Market, Major Resource Providers

Table 6: Global Targeted Alpha-Therapy Market, Major Manufacturers (Suppliers)

Table 7: Global Targeted Alpha-Therapy Market, Major Distributors And Channel Partners

Table 8: Global Targeted Alpha-Therapy Market, Key Technologies & Future Trends

Table 9: Global Targeted Alpha-Therapy Market, Major Trends

Table 10: Global Targeted Alpha-Therapy Market, Major End Users

Table 11: Global Targeted Alpha-Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Targeted Alpha-Therapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Targeted Alpha-Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Targeted Alpha-Therapy Market - TAM, US$ Billion, 2025

Table 15: Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Targeted Alpha-Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Targeted Alpha-Therapy Market - Company Scoring Matrix

Table 99: Bayer Aktiengesellschaft Financial Performance

Table 100: Novartis AG Financial Performance

Table 101: Lantheus Holdings Inc. Financial Performance

Table 102: Telix Pharmaceuticals Limited Financial Performance

Table 103: Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Performance

Table 104: Global Targeted Alpha-Therapy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Targeted Alpha-Therapy Market, Competitive Dashboard

Table 106: Global Targeted Alpha-Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By Isotope Type, 2025 – 2030

Table 108: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Table 109: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Targeted Alpha-Therapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Targeted Alpha-Therapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Targeted Alpha-Therapy Market, Supply Chain Analysis

Figure 4: Global Targeted Alpha-Therapy Market, Major Raw Material Providers

Figure 5: Global Targeted Alpha-Therapy Market, Major Resource Providers

Figure 6: Global Targeted Alpha-Therapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Targeted Alpha-Therapy Market, Major Distributors And Channel Partners

Figure 8: Global Targeted Alpha-Therapy Market, Key Technologies & Future Trends

Figure 9: Global Targeted Alpha-Therapy Market, Major Trends

Figure 10: Global Targeted Alpha-Therapy Market, Major End Users

Figure 11: Global Targeted Alpha-Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Targeted Alpha-Therapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Targeted Alpha-Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Targeted Alpha-Therapy Market - TAM, US$ Billion, 2025

Figure 15: Global Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Actinium-225, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Radium-223, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Lead-212, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Bismuth-213, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Targeted Alpha-Therapy Market, Sub-Segmentation Of Other Isotope Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Targeted Alpha-Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Targeted Alpha-Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Targeted Alpha-Therapy Market, Segmentation By Isotope Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Targeted Alpha-Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Targeted Alpha-Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Targeted Alpha-Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Targeted Alpha-Therapy Market - Company Scoring Matrix

Figure 99: Bayer Aktiengesellschaft Financial Performance

Figure 100: Novartis AG Financial Performance

Figure 101: Lantheus Holdings Inc. Financial Performance

Figure 102: Telix Pharmaceuticals Limited Financial Performance

Figure 103: Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Performance

Figure 104: Global Targeted Alpha-Therapy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Targeted Alpha-Therapy Market, Competitive Dashboard

Figure 106: Global Targeted Alpha-Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By Isotope Type, 2025 – 2030

Figure 108: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Figure 109: Global, Targeted Alpha-Therapy Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Alpha Hydroxy Acid Market Report 2026 - Global Outlook – By Product (Glycolic Acid, Lactic Acid, Citric Acid, Other Products), By Source (Natural, Synthetic), By Application (Cosmetics, Dermal) – Market Size, Trends, Str...

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2026 - Global Outlook – By Treatment Type (Symptomatic Drug Therapy, Supportive Care Therapy, Palliative Care), By Symptom Management (Seizure Management,...

Drugs For Hormonal Replacement Therapy Market Report 2026 - Global Outlook – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replac...

Alpha Methyldopa Market Report 2026 - Global Outlook – By Type (Oral, Intravenous Drip), By Purity Type (Purity (=98%, Purity (=99%), By Application (Parkinsonism, Hepatic Coma) – Market Size, Trends, Strategies, and For...

Hormone Therapy Market Report 2026 - Global Outlook – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route Of Administration (Oral, Parent...

mRNA Therapeutics Market Report 2026 - Global Outlook – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals...

Testosterone Replacement Therapy Market Report 2026 - Global Outlook – By Product Type (Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products), By Indication (Hypogonadism, Genetic Disorders...

Frequently Asked Questions

How big is the Targeted Alpha-Therapy Market?

The Targeted Alpha-Therapy market was valued at $1.03 billion in 2025, increased to $1.2 billion in 2026, and is projected to reach $2.25 billion by 2030.

What is the Targeted Alpha-Therapy market growth?

The global Targeted Alpha-Therapy market is expected to grow at a CAGR of 17.0% from 2026 to 2035 to reach $2.25 billion by 2035.

Who are the key players in Targeted Alpha-Therapy market?

Some Key Players in the Targeted Alpha-Therapy market Include, Bayer Aktiengesellschaft, Novartis AG, Lantheus Holdings Inc., Telix Pharmaceuticals Limited, Eckert & Ziegler Strahlen- und Medizintechnik AG, Actinium Pharmaceuticals Inc., RayzeBio Inc., ITM Isotope Technologies Munich SE, ARTBIO Inc., AdvanCell Pty Ltd., IONETIX Corporation, Abdera Therapeutics Inc., Aktis Oncology Inc., Alpha-9 Oncology Inc., Clarity Pharmaceuticals Pty Ltd., Nucleus RadioPharma, Oncoinvent AS, PanTera, Perspective Therapeutics Inc., RadioMedix Inc. .

What is the anticipated growth trend for the Targeted Alpha-Therapy market?

Major trend in this market includes: Advancements In Precision Alpha-Emitter Cancer Treatments. For further insights on this market. request a sample here

Which region has the most growth potential in the Targeted Alpha-Therapy market?

North America was the largest region in the targeted alpha-therapy market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the targeted alpha-therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.